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Abstract
Regular exercise training is considered healthy as it reduces the risk of cardiovascular
events and mortality. Nevertheless, athletes are not immune to the development of
cardiovascular diseases and recent studies reported a higher prevalence of coronary
artery calcifications and atherosclerotic plaques in athletes compared to less active
controls. These observations have raised many questions among sport scientists,
sports cardiologists, amateur athletes, and the general population. For example, Are
athletes (not) immune for coronary atherosclerosis? How to assess coronary athero-
sclerosis in athletes? What about chalk (calcified plaque) and cheese (mixed plaque)?
Does exercise intensity play a role? Are there sport-related differences? Are there
sex differences? Can sports medical evaluation detect coronary atherosclerosis? Do
athletes get worried? Should athletes get worried? How should athletes with coro-
nary atherosclerosis be managed? The goal of this review is to discuss the latest sci-
entific insights and to answer these important questions. Furthermore, we will
explore potential clinical implications and point out directions for further research.
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1 | INTRODUCTION
“If we could give every individual the right amount of
nourishment and exercise, not too little and not too much,
we would have found the safest way to health”
Hippocrates, 460-377 BC
It has been known for more than 2000 years that habitual physi-
cal activity and regular exercise training importantly contribute to a
healthy lifestyle. Sufficient physical activity and exercise are associ-
ated with remarkable reductions in cardiovascular events1-5 and
increased longevity.6 Only 15 minutes of physical activity per day is
associated with a 14% reduction in all-cause mortality.4 In contrast,
insufficient physical activity is responsible for a population attribut-
able fraction of 12% for cardiovascular disease (CVD) mortality.7 As
such, exercise is one of the most effective measures to reduce the risk
of CVD in general, and coronary heart diseases in particular as ≥44%
of CVD deaths are attributable to atherosclerotic coronary heart dis-
ease. Exercise-induced CVD risk reductions do, therefore, translate to
large health benefits as CVDs are the primary cause of death world-
wide, accounting for ±18 million deaths per year (±31% of total
mortality).7
The common dogma is that more exercise yields greater health
benefits. However, recent studies reported intriguing findings on the
effects of long-term high-volume high-intensity exercise training on
the prevalence and severity of atherosclerotic coronary heart disease
among amateur athletes.8-10 A higher prevalence of coronary artery
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calcifications (CACs) and atherosclerotic plaques has been found in
athletes vs controls, with a higher CAC and plaque prevalence in the
most active vs least active athletes. These findings have raised many
questions among healthcare professionals, sports scientists, and ath-
letes. The goal of the present review is to discuss the latest insights
from this field of research and to provide evidence-based answers to
these eminent questions.
2 | ARE ATHLETES (NOT) IMMUNE TO
CORONARY ATHEROSCLEROSIS?
The development and progression of CVD is importantly depen-
dent on lifestyle factors, including physical activity and nutrition.7
It has been suggested that atherosclerosis is typically a disease of
modern society, as physical inactivity and atherogenic diets are
common nowadays. However, when researchers made computed
tomography (CT) scans of mummies from ancient Egypt, 20 out of
44 mummies (45%) had atherosclerosis at an estimated age of 45
± 9 years.11 Of those mummies, two had definite coronary athero-
sclerosis, the earliest documentation of coronary atherosclerosis.
A postmortem pathology study from 1960 investigated coronary
atherosclerosis in men aged 30 to 60 years who died suddenly
from accidents, homicide, or suicide.12 Study participants were
classified as sedentary (eg, accountant, bank clerk, and chauffeur)
or physically active (eg, construction worker, gardener, and
plumber) based on their occupation history. Surprisingly, a similar
degree of coronary atherosclerosis was found among the seden-
tary and physically active group, suggesting that development of
coronary atherosclerosis was not associated with habitual physical
activity.12 In 1977, Bassler described a case series of runners who
had died.13 Interestingly, autopsy reports revealed that none of
the marathon runners died of atherosclerotic coronary artery dis-
ease, suggesting that marathon runners could be immune for coro-
nary atherosclerosis as they avoided tobacco smoking and
unhealthy diets and covered great distances on foot.13 Unfortu-
nately, a 1979 case series of four marathon runners reported
autopsy-proven coronary atherosclerosis, which rejected the
Bassler's hypothesis that long-distance runners are protected from
the development of coronary heart disease.14 In conclusion, the
development of atherosclerosis is importantly dependent on life-
style factors such as insufficient physical activity and an athero-
genic diet, but athletes are not immune to atherosclerosis.
3 | HOW TO ASSESS CORONARY
ATHEROSCLEROSIS IN ATHLETES?
Although older studies relied on autopsy to determine the presence
and severity of coronary atherosclerosis, the development of imaging
techniques changed the availability of methods to assess coronary
heart disease characteristics. Nowadays, coronary atherosclerosis is
typically measured non-invasively using a CT scan. This can be done
with or without a contrast agent. A non-contrast CT scan allows quan-
tification of CAC by calculating a CAC score (CACS).15 The Agatston
CACS is calculated by multiplying the area of each calcification by
1, 2, 3, or 4 depending on the density of the area, and summing up
the scores for all slices. The density score is based on the highest
Hounsfield units (HU) of the area, with a density score of 1 for HU
130 to 199, 2 for 200 to 299, 3 for 300 to 399, and 4 for ≥400 HU.16
CAC scoring only includes areas with a density ≥130 HU and ≥1 mm2.
The CACS is related to the coronary atherosclerotic burden and a
strong predictor for future CVD.17 In a study of 4425 patients
followed up for 3 years, the probability of major adverse cardiac
events was estimated for CACS categories. Patients without CAC
(a CACS of 0) had a major adverse cardiac event rate of 2.1%. The rate
of cardiac events was 12.9% for those with CACS >0 to 100, 16.3%
for those with CACS >100 to 400, and 33.8% for those with CACS
>400, indicating the strong prognostic value of CAC.18 As such, CACS
are widely used to assess atherosclerotic burden and future cardiovas-
cular risk in an easy, non-invasive way. Interestingly, although the
CACS itself is a multiplication of CAC area and density, a distinction
can be made between the CV risk associated with increases in the
area and density of CAC regions. Higher CAC area (or volume) is asso-
ciated with a higher CVD risk, whereas a higher CAC density is associ-
ated with a lower risk of CVD.19
Using a contrast-enhanced coronary CT scan (coronary CT
angiography, CCTA), the lumen of the coronary arteries can also be
imaged and plaque characteristics can be determined. This allows
for determination of plaque morphology and divide plaques into
calcified, non-calcified, and mixed (both calcified and non-calcified
parts) plaques.20 The differentiation of plaques based on their
morphology into calcified, non-calcified, and mixed plaques impor-
tantly impacts the associated CV risk.18 For example, in the previ-
ously mentioned study of 4425 patients, calcified plaques were
associated with a 3-year major adverse cardiac event risk of 5.5%,
whereas this was 22.7% for non-calcified plaques and 37.7% for
mixed plaques.18 As CAC scoring only includes plaques with an
area of density ≥130 HU and ≥1 mm2, plaque components below
that threshold are not included in the CACS. This means that non-
calcified or only minimally calcified, mixed plaque (“cheese”) can
only be detected using a contrast-enhanced CT. Moreover, CCTA
also allows for assessment of high-risk plaque features such as the
napkin-ring sign, positive remodeling, low-attenuation (<30 HU)
plaque, and spotty calcification, which are also associated with
worse prognosis.21
CT scanning uses radiation to construct images and tremendous
efforts have been made over the last decades to reduce the radiation
dose associated with CT scanning. A routine CCTA examination can
now be performed at 2 to 4 mSv, while newer technologies even
allow CCTA acquisitions at <1 mSv.22 CAC scoring also requires
±1 mSv of radiation, but recent efforts suggest CAC scoring can be
improved and done at lower doses requiring ±0.2 to 0.3 mSv of radia-
tion.23 Although the associated radiation dose is not high, it is not
negligible and thus performing CAC scoring or CCTA should clearly be
of value to the individual.
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4 | DO CORONARY ATHEROSCLEROSIS
CHARACTERISTICS DIFFER BETWEEN
ATHLETES AND CONTROLS?
Although several studies demonstrated that athletes are not immune to
coronary atherosclerosis, it was generally assumed that coronary athero-
sclerosis would be less prevalent in athletes compared to the general pop-
ulation. In 2008, Möhlenkamp et al studied 108 male marathon runners
and compared them to 864 age-matched and 216 age- and risk factor-
matched control subjects from the Heinz-Nixdorf Recall study.10 They
found that the German marathon runners had similar CACS compared to
age-matched controls, but higher CACS compared to the controls matched
for both age and risk factors (Table 1). These findings were surprising and
suggested more coronary atherosclerosis in athletes vs controls. Criticists
raised the possibility that the inclusion criteria may have caused bias. Par-
ticipants older than 50 years with ≥5 marathon completion in the previous
3 years were recruited for the study. Hence, marathoners might have
relatively recently adopted an active lifestyle, which improved their risk
factors whereas their CACS reflected their prior exposure to higher risk
factors. Nevertheless, Merghani et al confirmed findings from the Ger-
man study and reported that male British athletes had higher CACS
than control subjects (median CACS of 86 vs 3, P = .02), but only in
those with prevalent CAC9 (Table 1). Similarly, Aengevaeren et al found
among 284 Dutch male athletes that the most active athletes (>2000
metabolic equivalent of task [MET]-min/wk) more often had CAC (68%,
adjusted odds ratio [ORadjusted]: 3.2; 95% confidence interval [CI]:
1.6-6.6) compared with the least active athletes (<1000 MET-min/wk,
43%).8 However, CACS did not differ between the athletes with
prevalent CAC in their study. DeFina et al studied 21 758 generally
healthy American men and divided them based on their physical activity
level into individuals performing <1500, 1500 to 2999, and ≥ 3000
MET-min/wk.24 The most active individuals were more likely to have a
CACS >100 (ORadjusted: 1.11; 95% CI: 1.03-1.20) compared with indi-
viduals performing less physical activity. Collectively, these findings
indicate that athletes are more likely to have high CACS than controls.
Aengevaeren et al and Merghani et al also performed a contrast-
enhanced CT scan following CAC scoring. Prevalence of atherosclerotic
plaques was higher in male athletes compared to controls (44% vs 22%)9
and in the most active athletes (77%; ORadjusted: 3.3; 95% CI: 1.6-7.1)
compared to the least active athletes (56%).8 However, plaque morphol-
ogy differed significantly across groups. Athletes demonstrated predomi-
nantly calcified plaques (73%) instead of mixed plaques (23%), whereas
controls had fewer calcified plaques (31%, P = .0006) and predominantly
mixed plaques (62%, P = .0002).9 Similarly, the most active athletes had
less often atherosclerotic plaques of a mixed morphology (48%;
ORadjusted: 0.35; 95% CI: 0.15-0.85) compared with the least active ath-
letes (69%). The most active athletes also had more often only calcified
plaques compared to the least active athletes (38% vs 16%; ORadjusted:
3.57; 95% CI: 1.28-9.97). These findings indicate a more benign plaque
composition in athletes vs controls, as calcified plaques are associated
with a lower cardiovascular risk than mixed plaques.18 The comparison of
atherosclerosis induced health risks between athletes and the general
population is therefore inappropriate, as “chalk” (ie, low-risk calcified
plaques) has different risk estimates compared to cheese (ie, higher risk
non-calcified/mixed plaques). These observations emphasize that person-
alized medicine is needed in the treatment of coronary atherosclerosis.
TABLE 1 Coronary atherosclerosis characteristics across studies comparing athletes and controls
















































36 (0-217) 38 (3-187) 12 (0–78)aa 0 0 9.4 (0-60.9) 0 (0-43.5)aa NA NA
CACS in CAC
>0bb (AU)




NA NA NA 44 22aa 77% 56aa NA NA
Note: Data shown as percentage or with 95% confidence interval or median (interquartile range).
Abbreviations: AU, Agatston units; CAC, coronary artery calcification; CACS, CAC score; MET, metabolic equivalent of task; NA, not available; OR, odds
ratio; RF, risk factor.
aSignificantly (P < .05) different from athletes/most active cohort.
bCACS only in CAC > 0 thus lower number of participants.
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5 | DOES EXERCISE INTENSITY PLAY
A ROLE?
Exercise encompasses a wide subset of activities that can be per-
formed at a different frequency, duration, and intensity. Little is
known about the influence of exercise intensity on coronary athero-
sclerosis. Aengevaeren et al explored the association between differ-
ent exercise intensities and found that only very vigorous intensity
exercise (≥9 MET) was significantly associated with increased CAC
(ORadjusted: 1.47; 95% CI: 1.14-1.91) and plaque (ORadjusted: 1.56; 95%
CI: 1.17-2.08).8 Follow-up studies are needed to confirm these initial
findings, whereas mechanistic studies may unravel how and why
higher exercise intensities are associated with more coronary
atherosclerosis.
6 | ARE THERE SPORT-RELATED
DIFFERENCES?
Most studies assessing coronary atherosclerosis in middle-aged ath-
letes recruited predominantly runners and cyclists. Aengevaeren et al
investigated whether there were differences between runners (n = 72,
25%), cyclists (n = 81, 29%), and athletes performing other types of
sport (n = 131, eg, soccer [n = 29], hockey [n = 11], and water polo
[n = 10]). They found that cyclists had a lower prevalence of athero-
sclerotic plaques (ORadjusted: 0.41; 95% CI: 0.19-0.87) and a trend
toward lower prevalence of CAC (ORadjusted: 0.55; 95% CI: 0.26-1.16)
compared with runners (Figure 1). Moreover, they found that among
athletes with plaques, cyclists had a somewhat more benign athero-
sclerotic plaque composition with a similar prevalence of mixed
plaques (ORadjusted: 0.78; 95% CI: 0.31-1.94) and more often only cal-
cified plaques (ORadjusted: 3.59; 95% CI: 1.14-11.31) compared with
runners.25 Merghani et al also compared male runners (n = 82) and
cyclists (n = 24), and found no significant differences with respect to
CAC prevalence (50% vs 42%), CACS >100 (17% vs 25%), CACS
>70th percentile (16% vs 13%), or a luminal stenosis ≥50% (8.5% vs
4.2%). A potential explanation for the different outcomes across stud-
ies may relate to the relatively low sample size of subgroups. More-
over, athletes may perform more than one sport, thereby making the
impact of a single sport difficult and uncertain to elucidate.
Future studies with larger populations are needed to provide
definitive answers to sport-related differences, whereas inclusion of
athletes performing other types of sports (ie, swimming, football, soc-
cer, etc.) are also warranted.
F IGURE 1 Prevalence of coronary atherosclerosis and plaque morphology across sporting disciplines in participants from the Measuring
Athletes' Risk of Cardiac events (MARC) study. CAC, coronary artery calcification; OR, odds ratio; REF, reference
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7 | ARE THERE SEX DIFFERENCES?
The large majority of participants in the current studies have been
males. This is mostly due to the fact that males have a higher prev-
alence of coronary atherosclerosis and a higher risk of sudden car-
diac death during exercise.26,27 However, there have been several
studies investigating female athletes. Merghani et al included
46 female athletes and 38 female controls.9 They found no differ-
ences in CAC prevalence (22% vs 32%, P = .33), CACS ≥100 (7% vs
11%, P = .62), or plaque prevalence (15% vs 21%, P = .57). The
authors indicated that this might have been due to a relatively low
power due to the inclusion of premenopausal women who are rela-
tively protected from coronary atherosclerosis. Roberts et al stud-
ied 26 female marathon runners and compared them to
28 sedentary women referred for CCTA to evaluate coronary
artery disease.28 The authors found a lower plaque prevalence
(19% vs 50%, P = .01) in the athletic women. However, the control
subjects had a significantly higher body mass index as well as a
higher prevalence of hypertension, hyperlipidemia, smoking his-
tory, and family history for coronary artery disease, questioning
the validity of this comparison. DeFina et al found no association
between physical activity categories and prevalence of CACS ≥100
in female participants, whereas this association was present for
men.24 Although limited evidence is available, current data suggest
that the association between exercise and coronary atherosclero-
sis is weaker in female athletes compared to their male counter-
parts, which may be mediated by estrogen.
8 | CAN SPORTS MEDICAL EVALUATION
DETECT CORONARY ATHEROSCLEROSIS?
A sports medical evaluation typically includes taking a medical history,
physical examination, resting electrocardiogram, and bicycle exercise
test with electrocardiogram. However, Braber et al previously showed
that among 318 middle-aged male amateur athletes who underwent a
sports medical evaluation without abnormalities, as much as 19% had
a CACS ≥100 and/or ≥50% stenosis29 (Figure 2). These findings sug-
gest that a substantial proportion of asymptomatic athletes can have
subclinical atherosclerosis that goes undetected during sports medical
evaluations and may place them at risk of (exercise-induced) cardiac
events.
Braber et al also calculated the number needed to screen with
CAC scoring and with CAC scoring plus CCTA to prevent one cardio-
vascular event (ie, angina pectoris, myocardial infarction, coronary
revascularization, resuscitated cardiac arrest, stroke, or cardiovascular
death) within 5 years.29 The estimated number needed to screen
using only CAC scoring was 183 (95% CI: 144-236) and 159 (95% CI:
128-201) for CAC scoring plus CCTA. Although it is currently not rec-
ommended to implement CAC screening programs among middle-
aged and older athletes, one could argue that this might become an
option in the future considering the ongoing debate on improving car-
diovascular screening of athletes and especially given the high nega-
tive predictive value of a CACS of zero.30,31
9 | DO ATHLETES GET PSYCHOLOGICAL
STRESS FOLLOWING CORONARY CT?
CAC scoring is an increasingly popular diagnostic tool and many ath-
letes have had CAC scoring, either for research or clinical purposes.
Although CAC scoring provides a lot of valuable prognostic informa-
tion, it may also increase psychological distress in athletes when either
they have intermediate CACS not requiring treatment or when they
have high(er) CACS requiring medication. If coronary CT is to be more
widely implemented in the future, this is an important factor to take
into consideration, especially in primary prevention. Schurink et al
investigated the psychological distress in 275 athletes who underwent
CAC scoring and CCTA for research purposes.32 They found that car-
diovascular screening including a sports medical evaluation and car-
diac CT did not increase overall psychological distress in a cohort of
middle-aged male amateur athletes. There was only one individual
(1/275, 0.4%) who had experienced clinically relevant psychological
distress following the examinations which showed substantial coro-
nary artery disease, but overall the majority felt safer when exercising
(59%), satisfied with their participation (94%), and would participate
again (95%).32
F IGURE 2 Prevalence of CACS and obstructive (>50%) coronary
artery disease in participants from the Measuring Athletes' Risk of
Cardiac events (MARC) study. CACS, coronary artery calcification
score; CCTA, coronary computed tomography angiography
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10 | SHOULD ATHLETES GET WORRIED
ABOUT THEIR CARDIOVASCULAR RISK?
Although CAC is associated with increased cardiovascular risk, DeFina
et al showed that among individuals with CACS <100 all-cause mor-
tality was lower in the most active individuals (≥3000 MET-min/wk,
hazard ratio [HR]: 0.52; 95% CI: 0.29-0.91) compared with the least
active individuals (<1500 MET-min/wk), whereas among individuals
with CACS >100 the risk was not significantly different between
physical activity volume groups (HR: 0.77; 95% CI: 0.52-1.15).24 Simi-
larly, Arnson et al studied the impact of self-reported exercise on the
relationship between CACS and mortality among asymptomatic
patients.33 Patients were asked: “On a scale of 0 to 10, how much do
you exercise (0—none, 10—always)?” This question was then catego-
rized as “no exercise” (score of 0 or 1), “low exercise” (score of 2-5),
“moderately active” (score of 6-8), and “highly active” (score of 9 and
10). With the highly active as reference group, being moderately
active had an HR of 1.29 (95% CI: 0.86-1.95) for all-cause mortality,
low exercise had an HR of 1.56 (95% CI: 1.06-2.30), and no exercise
had an HR of 2.35 (95% CI: 1.49-3.70) after adjusting for CACS and
potential confounders. These data indicate that individuals with
substantial CAC who perform high volumes of exercise have a lower
mortality risk than their less active and inactive peers.
Data from epidemiological studies show a higher life expectancy
in athletes compared to less physically active control subjects. For
example, both elite34,35 and amateur6 athletes live longer than the
general population. Exercise training increases longevity by approxi-
mately 3 years with the most benefit for endurance sports.6,35 The
lower risk of a given CACS and increased longevity in athletes may be
explained by other beneficial coronary adaptations to exercise, such
as increased epicardial coronary diameter, capillary density, and func-
tion.36-38 Hence, athletes should not get worried about the long-term
risks of potential detrimental adaptations to the athletes heart since
they live ±3 years longer than the general population.
11 | HOW SHOULD ATHLETES WITH
CORONARY ATHEROSCLEROSIS BE
MANAGED?
Treatment depends on the athlete's risk of CVD. Athletes should be
questioned about cardiac symptoms, risk factors, and family history of
F IGURE 3 Flowchart for clinical management of athletes who underwent CAC scoring and/or CCTA. CAC, coronary artery calcification;
CACS, CAC score; CCTA, coronary computed tomography angiography; CVD, cardiovascular disease. aIf CCTA was performed
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CVD. Athletes may present with atypical symptoms such as reduced
exercise performance, shortness of breath, or fatigue instead of typi-
cal angina. Athletes with cardiac symptoms should be investigated
and managed as the general population.
There are no specific guidelines for the management of asymp-
tomatic athletes with coronary atherosclerosis, but we have recently
suggested a potential management strategy.39 In short, cholesterol-
lowering therapy should be advised according to recent
guidelines,30,40 taking into account, among others, the athlete's pref-
erences concerning medication, their family history, and non-calcified
plaque on CCTA. If athletes have high CACS (≥400), they should be
advised to start high-intensity statin therapy regardless of CVD risk
score and be informed to strictly control their cardiovascular risk fac-
tors (eg, blood pressure, glucose level, and smoking). Although its use
in primary prevention has recently been debated, perhaps aspirin can
be considered for individuals with (very) high CACS who are not at
increased bleeding risk.41 Subsequent anatomical or functional testing
is heavily dependent on local availability and costs of different tests.
CCTA can be considered as an anatomical test to evaluate coronary
stenoses, plaque morphology, and number and location of plaques.
Stress (imaging) tests can be used as a functional measure of inducible
ischemia. We suggest that for athletes with CACS ≥400, a CCTA to
evaluate luminal narrowing or stress (imaging) test to evaluate poten-
tial ischemia should be considered, whereas for athletes with luminal
stenoses >50%, a stress (imaging) test should be considered to detect
potential myocardial ischemia. These should not necessarily lead to
coronary interventions, as there is currently no evidence that a stent
will increase life expectancy in an asymptomatic athlete, but could
provide maximal heart rate guidelines and guide training schedules
and additional medical therapy in individuals with ischemia. Also, in
certain cases, invasive coronary angiography with fractional flow
reserve measurements can be considered based on the anatomical
information from CCTA. Figure 3 provides a basic schematic summary
of these considerations.
Recommendations from the European Sports Cardiology
Section for participation in leisure time or competitive sports for
athletes-patients with coronary artery disease provide guidance for
participation in sports for athletes with asymptomatic coronary ath-
erosclerosis.42 In short, athletes should be assessed for inducible
ischemia and coronary risk factors. Exercise testing, potentially
followed by stress imaging tests, to assess functional ischemia is
advised and aggressive risk factor management according to the
guidelines is important. In general, athletes may be advised to partici-
pate in all types of exercise if they have no evidence of inducible
ischemia or arrhythmias and have a normal ejection fraction.42
12 | REMAINING QUESTIONS AND
FUTURE PERSPECTIVES
There are still several missing answers to questions regarding the rela-
tionship between exercise and coronary atherosclerosis, such as: How
does coronary atherosclerosis progress over time in athletes? What
are explanations for this association? What is the clinical relevance of
increased coronary atherosclerosis in athletes?
Different international research groups are studying coronary
atherosclerosis in athletes and this will provide more data in the
coming years. The British research group (Merghani et al9) is cur-
rently increasing the size of their female cohort, providing more
information on the relationship between exercise and coronary ath-
erosclerosis among female athletes in the near future. The Dutch
research group (Aengevaeren et al8) is currently performing a follow-
up study of their cohort, establishing the first longitudinal athletic
cohort with contrast-enhanced CT scans. This will provide more data
on longitudinal effects of exercise on CAC and plaque (morphology).
The American research group (DeFina et al24) is following a large
cohort over time to investigate whether exercise volume is associ-
ated with the development of CAC. These studies together will pro-
vide new data to either strengthen or reject the current findings and
will hopefully answer some of the remaining questions. The mecha-
nisms explaining the findings of increased coronary atherosclerosis
in athletes are uncertain and likely complex. The existing literature
and studies cannot answer this question. Thus, animal studies and
perhaps physiological clinical studies will likely be necessary to
investigate which mechanistic pathways are responsible for these
observations.
13 | CONCLUSIONS
Exercise is healthy and substantially reduces the risk of cardiovascular
events and mortality. However, recent studies suggest increased coro-
nary atherosclerosis in athletes. The apparent paradox of increased
coronary atherosclerosis despite lower cardiovascular risk and
increased longevity in the (most active) athletes may be explained by
the observations of more benign plaque morphology (chalk instead of
cheese) in combination with beneficial exercise-induced coronary
adaptations. Future longitudinal studies are required to shed more
light on potential mechanisms, clinical relevance, and optimal manage-
ment of coronary atherosclerosis in athletes.
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